Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML

Blood (2019) 134 (Supplement_1): 831.

https://doi.org/10.1182/blood-2019-126065

Published: 2019

Journal Articles

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Clinton Lewis, MD, Haesook T. Kim, PhD, Corey S. Cutler, MD MPH, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Rizwan Romee, MD, Brett Glotzbecker, Prashant Nageshwar, MD, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Paul Richardson, Robert J. Soiffer, MD, Vincent T. Ho, MD

Blood (2018) 132 (Supplement 1): 3376.

https://doi.org/10.1182/blood-2018-99-113130

Published: 2018

Journal Articles

Incidence of Post-Hematopoietic Stem Cell Transplantation (HSCT) Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) without Hyperbilirubinemia at Diagnosis and Efficacy of Defibrotide in an Expanded-Access Program

Selim Corbacioglu, MD, Nancy A. Kernan, Antonio Pagliuca, Robert Ryan, William Tappe, Paul Richardson

Blood (2018) 132 (Supplement 1): 2080.

https://doi.org/10.1182/blood-2018-99-117173

Published: 2018

Journal Articles

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Bilawal Ahmed, MD, Beenish Zulfiqar, MD

Blood (2017) 130 (Supplement 1): 4757.

https://doi.org/10.1182/blood.V130.Suppl_1.4757.4757

Published: 2017

Journal Articles

Pharmacokinetic Analysis of Continuous Intravenous Infusion of Lipo-Prostaglandin E1 As a Prophylaxis of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation

Che Ry Hong, Yewon Choi, Jaeseong Oh, Jung Sunwoo, Kyung Taek Hong, Jung Yoon Choi, Kyung-Sang Yu, Kyung Duk Park, MD PhD, Hee Young Shin, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2016) 128 (22): 2214.

https://doi.org/10.1182/blood.V128.22.2214.2214

Published: 2016

Journal Articles

A Multicenter Prospective Phase II Study of Antithrombin-III Based Treatment for Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation

Che Ry Hong, Ji Won Lee, MD PhD, Hyeon-Seok Eom, Keon Hee Yoo, Jong Wook Lee, Ho Joon Im, Hee Young Shin, MD PhD, Hyoung Jin Kang, MD PhD

Blood (2016) 128 (22): 3387.

https://doi.org/10.1182/blood.V128.22.3387.3387

Published: 2016

Journal Articles

Diagnosis of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease of the Liver: Problems of Interpretation

Liisa Volin, MD PhD, Riitta Niittyvuopio, MD PhD, Jouni Heiskanen, MD, Vesa Lindstrom, MD, Leila Sahlstedt, MD PhD, Tapani Ruutu, MD PhD

Blood (2015) 126 (23): 1918.

https://doi.org/10.1182/blood.V126.23.1918.1918

Published: 2015

Journal Articles

Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Diagnostic Patterns Among United States and European Union Hematologists and Oncologists Managing Patients Receiving Stem Cell Transplantation

Tim Corn, MD, Peter Ogram, Tina Doede, MS, MBA

Blood (2015) 126 (23): 4732.

https://doi.org/10.1182/blood.V126.23.4732.4732

Published: 2015

Journal Articles

A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)

Tiffany P. Quock, PhD MS, Zheng-Yi Zhou, PhD, Byran Dai, MS, Wenxi Tang, MS, Kathleen F. Villa, MS

Blood (2015) 126 (23): 3273.

https://doi.org/10.1182/blood.V126.23.3273.3273

Published: 2015

Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Selim Corbacioglu, MD, Enric Carreras, MD PhD, Mohamad Mohty, MD PhD, Antonio Pagliuca, MD FRCP, FRCPath, Maria Ballabio, MD, Robin L. Hume, MS, Valeria Bandiera, Giorgia Finetto, Paul G. Richardson

Blood (2014) 124 (21): 1138.

https://doi.org/10.1182/blood.V124.21.1138.1138

Published: 2014

Journal Articles

Anicteric Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation in Children

Jeffrey Naples, DO, Micah Skeens, RN, MS, PNP, Rajinder Bajwa, MBBS, MD MRCP

Blood (2014) 124 (21): 5849.

https://doi.org/10.1182/blood.V124.21.5849.5849

Published: 2014

Journal Articles

HSCT-Associated Hepatic VOD Is Initiated With Preceding Appearance Of Unusually Large Von Willebrand Factor Multimers In Patient Plasmas

Masaki Hayakawa, MD, Masanori Matsumoto, MD, PhD, Yumi Yoshii, MD, Hideo Yagi, MD, PhD, Hiroshi Kimura, MD, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2013) 122 (21): 3625.

https://doi.org/10.1182/blood.V122.21.3625.3625

Published: 2013

Journal Articles

Nationwide Survey of Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome: On Behalf of Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Kimikazu Yakushijin, MD, Yoshiko Atsuta, MD, Doki Noriko, MD, Akira Yokota, MD, Heiwa Kanamori, MD, Toshihiro Miyamoto, MD, Hisashi Sakamaki, MD, PhD, Hiromasa Yabe, MD, Yasuo Morishima, MD, Koji Kato, MD, Ritsuro Suzuki, MD, Takahiro Fukuda, MD

Blood (2013) 122 (21): 2051.

https://doi.org/10.1182/blood.V122.21.2051.2051

Published: 2013

Journal Articles

Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Chatchawin Assanasen, MD, Rony Skaria, MD, Maria G. Falcon, MD, Victor Saldivar, MD

Blood (2012) 120 (21): 4303.

https://doi.org/10.1182/blood.V120.21.4303.4303

Published: 2012

Journal Articles

Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia

Athanasios Papadopoulos, Sr., George Ntaios, Georgia Kaiafa, Fotios I Girtovitis, Zoi Saouli, Zisis Kontoninas, Michael D. Diamantidis, Charalambos Andreadis, Christos Savopoulos, Apostolos Hatzitolios

Blood (2008) 112 (11): 3949.

https://doi.org/10.1182/blood.V112.11.3949.3949

Published: 2008

Journal Articles

Treatment of Diffuse Large B-Cell Lymphoma of the Liver with Yttrium-90 Microsphere Embolization.

Heather L. Benjamin, MD, Timothy S. Fenske, MD, Steven H. Kroft, MD, Eric J. Hohenwalter, MD, William S. Rilling, MD

Blood (2007) 110 (11): 4510.

https://doi.org/10.1182/blood.V110.11.4510.4510

Published: 2007

Journal Articles

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial.

Blood (2006) 108 (11): 43.

https://doi.org/10.1182/blood.V108.11.43.43

Published: 2006

Journal Articles

Primary Amyloidosis Treated with Bortezomib with a Clinical and Radiological Response.

Veena S. Fauble, MD, Ila Shah-Reddy, MD

Blood (2006) 108 (11): 5111.

https://doi.org/10.1182/blood.V108.11.5111.5111

Published: 2006

Journal Articles

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

Blood (2004) 104 (11): 350.

https://doi.org/10.1182/blood.V104.11.350.350

Published: 2004

NARROW

Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Incidence of Post-Hematopoietic Stem Cell Transplantation (HSCT) Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) without Hyperbilirubinemia at Diagnosis and Efficacy of Defibrotide in an Expanded-Access Program

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Pharmacokinetic Analysis of Continuous Intravenous Infusion of Lipo-Prostaglandin E1 As a Prophylaxis of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation

A Multicenter Prospective Phase II Study of Antithrombin-III Based Treatment for Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation

Diagnosis of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease of the Liver: Problems of Interpretation

Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Diagnostic Patterns Among United States and European Union Hematologists and Oncologists Managing Patients Receiving Stem Cell Transplantation

A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Anicteric Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation in Children

HSCT-Associated Hepatic VOD Is Initiated With Preceding Appearance Of Unusually Large Von Willebrand Factor Multimers In Patient Plasmas

Nationwide Survey of Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome: On Behalf of Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Chemotherapy Toxicity Related to Non-Alcoholic Fatty Liver Disease (NAFLD) in an Adolescent with Pre-B Cell Acute Lymphoblastic Leukemia

Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia

Treatment of Diffuse Large B-Cell Lymphoma of the Liver with Yttrium-90 Microsphere Embolization.

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial.

Primary Amyloidosis Treated with Bortezomib with a Clinical and Radiological Response.

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only